Liposome-bound Zn(II)-phthalocyanine. Mechanisms for cellular uptake and photosensitization

Journal of Photochemistry and Photobiology B: Biology

Volumn 45, Issue 2-3, 1998, Pages 150-159

  Rodal, Gry Hege ^a   Rodal, Siv Kjersti ^a   Moan, Johan ^a   Berg, Kristian ^a  

^a Center of Clinical Epidemiology   (Norway)

Author keywords

Intracellular localization; Photodynamic; Zinc(II) phthalocyanine

Indexed keywords

CYTOCHROME C OXIDASE; GALACTOSYLTRANSFERASE; LIPOSOME; N ACETYL BETA GLUCOSAMINIDASE; PHOTOFRIN I; PHTHALOCYANINE ZINC; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; CULTURE MEDIUM; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; FEMALE; GOLGI COMPLEX; HUMAN; HUMAN CELL; INCUBATION TIME; LIGHT EXPOSURE; MITOCHONDRION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SERUM; TEMPERATURE; UTERINE CERVIX CARCINOMA;

DRUG CARRIERS; GALACTOSYLTRANSFERASES; HUMANS; INDOLES; LIPOSOMES; NADPH-FERRIHEMOPROTEIN REDUCTASE; ORGANOMETALLIC COMPOUNDS; PHOTOSENSITIVITY DISORDERS; PHOTOSENSITIZING AGENTS; TEMPERATURE; TUMOR CELLS, CULTURED; ZINC;

EID: 0032171113     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00175-4     Document Type: Article

References (54)

1. [1] H.I. Pass, Photodynamic therapy in oncology: mechanisms and clinical use, J. Natl. Cancer Inst. 85 (1993) 443-456.
2. [2] I. Amato, Cancer therapy, Hope for a magic bullet that moves at the speed of light, Science 262 (1993) 32-33.
3. [3] Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K.E. Giercksky, J.M. Nesland, 5-aminolevulinic acid-based photodynamic therapy -clinical research and future challenges, Cancer 79 (1997) 2282-2308.
4. [4] S. Wan, J.A. Parrish, R.R. Anderson, M. Madden, Transmittance of nonionizing radiation in human tissues, Photochem, Photobiol. 34 (1981) 679-681.
5. [5] J.R. Darwent, I. McCubbin, D. Phillips, Excited singlet and triplet state electron-transfer reactions of aluminium (III) sulfonated phthalocyanines, J. Chem. Soc. Faraday Trans. 2 78 (1982) 347-357.
6. [6] K. Berg, J. Moan, Optimization of wavelength in photodynamic therapy in: J. Moser (Ed.), Photodynamic Tumor Therapy, 2nd and 3rd Generation Photosensitizers, Harwood Academic Publishers, Amsterdam, 1998, pp. 151-168.
7. [7] Q. Peng, J. Moan, G. Farrants, H.E. Danielsen, C. Rimington, Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy, Cancer Lett. 58 (1991) 17-27.
8. [8] K. Berg, J.C. Bommer, J. Moan, Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy. Cellular uptake studies, Cancer Lett. 44 (1989) 7-15.
9. [9] J. Moan, T. Christensen, P.B. Jacobsen, Photodynamic effects on cells in vitro labelled with hematoporphyrin derivative, Photobiochem. Photobiophys. 7 (1984) 349-358.
10. [10] J. Moan, K. Berg, H.B. Steen, T. Warloe, K. Madslien, Fluorescence and photodynamic effects of phthalocyanines and porphyrins in cells, in: B.W. Henderson, T.J. Dougherty (Eds.), Photodynamic Therapy: Basic Principles and Clinical Applications. Marcel Dekker, New York, 1992, pp. 19-36.
11. [11] K.W. Woodburn, N.J. Vardaxis, J.S. Hill, A.M. Kaye, J.A. Reiss, D.R. Phillips, Evaluation of porphyrin characteristics required for photodynamic therapy, Photochem. Photobiol. 55 (1992) 697-704.
12. [12] K. Nordbye, R. Oftebro, Establishment of four new cell strains from uterine cervix. I, Exp. Cell Res. 58 (1969) 458.
13. [13] T.T. Puck, S.J. Cieciura, H. Fisher, Clonal growth in vitro of human cell with fibroblastic morphology, J. Exp. Med. 106 (1957) 145-165.
14. [14] K. Berg, K. Madslien, J.C. Bommer, R. Oftebro, J.W. Winkelman, J. Moan, Light induced relocalization of sulfonated meso-tetraphenylporphines in NHIK 3025 cells and effects of dose fractionation, Photochem. Photobiol. 53 (1991) 203-210.
15. [15] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
16. [16] H. Beaufay, A. Amar-Costesec, E. Feytmans, D. Thines-Sempoux, M. Wibo, M. Robbi, J. Berthet, Analytical study of microsomes and isolated subcellular membranes from rat liver. I. Biochemical methods, J. Cell Biol. 61 (1974) 188-200.
17. [17] A.W. Brandli, G.C. Hansson, E. Rodriguez-Boulan, K. Simons, A polarized epithelial cell mutant deficient in translocation of UDP-galactose into the Golgi complex, J. Biol. Chem. 263 (1988) 16283-16290.
18. [18] S .L. Gibson, R, Hilf, Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo, Cancer Res. 43 (1983) 4191-4197.
19. [19] J. Moan, T. Christensen, Photodynamic inactivation of cancer cells in vitro. Effect of irradiation temperature and dose fractionation, Cancer Lett. 6 (1979) 331-335.
20. [20] J. Moan, E.O. Pettersen, T. Christensen, The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin, Br. J. Cancer 39 (1979) 398-407.
21. [21] K. Berg, J. Moan, Mitotic inhibition by phenylporphines and tetrasulfonated aluminium phthalocyanine in combination with light, Photochem. Photobiol. 56 (1992) 333-339.
22. [22] K. Berg, H.B. Steen, J.W. Winkelman, J. Moan, Synergistic effects of photoactivated tetra(4-sulfonatophenyl)porphine and nocodazole on microtubule assembly, accumulation of cells in mitosis and cell survival, J. Photochem. Photobiol. B: Biology 13 (1992) 59-70.
23. [23] K. Berg, The unpolymerized form of tubulin is the target for microtubule inhibition by photoactivated tetra(4-sulfonatophenyl)-porphine, Biochim. Biophys. Acta 1135 (1992) 147-153.
24. [24] K. Berg, J. Moan, J.C. Bommer, J.W. Winkelman, Cellular inhibition of microtubule assembly by photoactivated sulphonated meso-tetraphenylporphines, Int. J. Radiation Biol. 58 (1990) 475-487.
25. [25] K. Berg, Q. Peng, J.M. Nesland, J. Moan, Cellular responses to photodynamic therapy, in: G. Jori J. Moan, W. Star (Eds.), Photodynamic Therapy of Cancer, Proc. SPIE 2078, 1994, pp. 278-285.
26. [26] L.U. Cassimeris, P. Wadsworth, E.D. Salmon, Dynamics of microtubule depolymerization in monocytes, J. Cell Biol. 102 (1986) 2023-2032.
27. [27] F. Ginevra, S. Biffanti, A. Pagnan, R. Biolo, E. Reddi, G. Jori, Delivery of the tumour photosensitizer zinc(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo, Cancer Lett. 49 (1990) 59-65.
28. [28] L. Polo, G. Bianco, E. Reddi, G. Jori, The effect of different liposomal formulations on the interaction of Zn(II)-phthalocyanine with isolated low and high density lipoproteins, Int. J. Biochem. Cell Biol. 27 (1995) 1249-1255.
29. [29] K. Berg, J. Moan, Lysosomes as photochemical targets. Int. J. Cancer 59 (1994) 814-822.
30. [30] M. Dellinger, C. Vever-Bizet, D. Brault, O. Delgado, C. Rosenfeld, Cellular uptake of hydroxyethylvinyldeuteroporphyrin (HVD) and photoinactivation of cultivated human leukemia (REH6) cells, Photochem. Photobiol. 43 (1986) 639-647.
31. [31] R.M. Bohmer, G. Morstyr, Uptake of hematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature, and cell size, Cancer Res. 45 (1985) 5328-5334.
32. [32] A. Le Cam, P. Freychet, Neutral amino acid transport, Characterization of A and L systems in isolated rat hepatocytes, J. Biol, Chem. 252 (1977) 148-156.
33. [33] R.I. Macy, Anonymous Membrane Transport in Biology II, Springer, Berlin, 1979.
34. [34] B. van Deurs, O.W. Petersen, S. Olsnes, K. Sandvig, Delivery of internalized ricin from endosomes to cisternal Golgi elements is a discountinuous, temperature-sensitive process, Exp. Cell Res, 171 (1987) 137-152.
35. [35] C. Milanesi, C. Zhou, R. Biolo, G. Jori, Zn(II)-phthalocyanine as a photodynamic agent for tumours. II Studies on the mechanism of photosensitised tumour necrosis, Br. J. Cancer 61 (1990) 846-850.
36. [36] K. Berg, J. Moan, Lysosomes and microtubules as targets for photochemotherapy of cancer, Photochem. Photobiol. 65 (1997) 403-409.
37. [37] P.J. Bugelski, C.W. Porter, T.J. Dougherty, Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse, Cancer Res. 41 (1981) 4606-4612.
38. [38] G. Valduga, E. Reddi, S. Garbisa, G. Jori, Photosensitization of cells with different metastatic potentials by liposome-delivered Zn(II)-phthalocyanine, Int. J. Cancer 75 (1998) 412-417.
39. [39] J. Moan, S. Sommer, Uptake of the components of hematoporphyrin derivative by cells and tumours, Cancer Lett. 21 (1983) 167-174.
40. [40] J.D. Spikes, Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors, Photochem. Photobiol. 43 (1986) 691-699.
41. [41] K. Berg, J.C. Bommer, J. Moan, Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy. A study on the relative efficiencies of photoinactivation, Photochem. Photobiol. 49 (1989) 587-594.
42. [42] A. Andeoni, R. Cubeddu, S. De Silvestri, P. Laporta, F.S. Ambesi-Impiombato, M. Esposito, M. Mastrocinque, D. Tramontane, Effects of laser irradiation on hematoporphyrin-treated normal and transformed thyroid cells in culture, Cancer Res. 43 (1983) 2076-2080.
43. [43] J.P. Keene, D. Kessel, E.J. Land, R.W. Redmond, T.G. Truscott, Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds, Photochem. Photobiol. 43 (1986) 117-120.
44. 6 and aluminium phthalocyanine tetrasulphonate, in: R.H. Douglas, J. Moan, F. Dall'Acqua (Eds.), Light in Biology and Medicine, Plenum, New York, 1988, pp. 85-89.
45. [45] J. Moan, S. Sommer, Action spectra for hematoporphyrin derivative and Photofrin II with respect to sensitization of human cells in vitro to photoinactivation, Photochem. Photobiol. 40 (1984) 631-634.
46. [46] G. Valduga, G. Bianco, G. Csik, E. Reddi, L. Masiero, S. Garbisa, G. Jori, Interaction of hydro-or lipophilic phthalocyanines with cells of different metastatic potential, Biochem. Pharmacol. 51 (1996) 585-590.
47. [47] J.C. Stockert, A. Juarranz, A. Villanueva, M. Cañete, Photodynamic damage to HeLa cell microtubules induced by thiazine dyes, Cancer Chemother. Pharmacol 39 (1996) 167-169.
48. [48] A. Juarranz, A. Villanueva, V. Diaz, M. Cañete, Photodynamic effects of the cationic porphyrin, mesotetra(4N-methylpyridyl) porphine, on microtubules of HeLa cells, J. Photochem. Photobiol. B: Biol. 27 (1995) 47-53.
49. [49] Q. Peng, J. Moan, M. Kongshaug, J.F. Evensen, H. Anholt, C. Rimington, Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocy anine tetrasulfonate in nude mice bearing a human malignant tumor, Int. J. Cancer 48 (1991) 258-264.
50. [50] K. Benstead, J. V. Moore, The effect of fractionation of light treatment on necrosis and vascular function of normal skin following photodynamic therapy, Br. J. Cancer 58 (1988) 301-305.
51. [51] W.G. Love, B.C. Havenaar, P.J. Lowe, P.W. Taylor, Uptake of zinc(II)-phthalocyanine by HepG2 cells expressing the low density lipoprotein receptor: studies with the liposomal formulation CGP55847, in: G. Jori, J. Moan, W. Star (Eds.), Photodynamic Therapy of Cancer, Proc. SPIE 2078, 1994, pp. 381-388.
52. [52] C.L. Davies, T. Ranheim, Z. Malik, E.K. Rofstad, J. Moan,T. Lindmo, Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hypothermia and photodynamic treatment, Br. J. Cancer 58 (1988) 306-313.
53. [53] D. Kessel, Sites of photosensitization by derivatives of hematoporphyrin, Photochem. Photobiol. 44 (1986) 489-493.
54. [54] R. Hilf, R.S. Murant, U. Narayanan, S.L. Gibson, Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivative-induced photosensitization in R3230AC mammary tumors, Cancer Res. 46 (1986) 211-217.